Reading Room

Rewind Therapeutics to lead €2.9 million R&D collaboration to discover and develop novel drug candidates for myelin-related neurological diseases

New industry-academic collaboration leverages key areas of expertise in Flanders and is funded by the Flanders Innovation and Entrepreneurship (VLAIO) agency.

This website uses cookies for analytics purposes only without any commercial intent. Find out more here. Our privacy statement can be found here. Some content (videos, iframes, forms,...) on this website will only appear when you have accepted the cookies.